Hemophilia A Clinical Trials in Philadelphia, Pennsylvania

3 studies are recruiting for hemophilia a in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in healthy participants (Part A) and to evaluate the safety, tolerability, PK, PD, and efficacy of SR604 in participants with Hemophilia A or Hemophilia B, or Factor VII (FVII…

    Stage
    Phase 1
    Ages
    18 to 60
    Site
    Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia, Pennsylvania
    Locations
    10 in total
    Run by
    Equilibra Bioscience LLC

    See if you can join NCT06349473 on ClinicalTrials.gov

  2. Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

    Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not require "Early Termination" from the Phase 3 Study B7841005 and from the Phase 3 Study B7841008. Study B7841005: approxima…

    Stage
    Phase 3
    Ages
    1 to 74
    Site
    The Feinstein Institutes for Medical Research, Philadelphia, Pennsylvania
    Locations
    75 in total
    Run by
    Pfizer

    See if you can join NCT05145127 on ClinicalTrials.gov

  3. Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

    A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatment through prior participation in a Pfizer-sponsored clinical trial. Data collection and participa…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia, Pennsylvania
    Locations
    23 in total
    Run by
    Pfizer

    See if you can join NCT05568719 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.